Search filters

List of works by Giacomo Lus

"Borderline" idiopathic CD4+ T-cell lymphocytopenia presenting with atypical progressive multifocal leukoencephalopathy

scientific article published on 29 September 2020

A cluster of progranulin C157KfsX97 mutations in Southern Italy: clinical characterization and genetic correlations.

scientific article published on 11 October 2016

Abnormal accumulation of tTGase products in muscle and erythrocytes of chorea-acanthocytosis patients

scientific article published in October 2002

Associations between cognitive impairment at onset and disability accrual in young people with multiple sclerosis

scientific article published on 02 December 2019

Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy

scientific article published on 11 February 2010

Azathioprine and interferon beta(1a) in relapsing-remitting multiple sclerosis patients: increasing efficacy of combined treatment

scientific article

Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview

scientific article

Diffuse glioblastoma resembling acute hemorrhagic leukoencephalitis.

scientific article published in October 2017

Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis

scientific article published on 06 June 2020

Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis

scientific article published on 16 September 2020

Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity

scientific article published on 09 May 2016

Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases.

scientific article

Epstein Barr virus infection reactivation as a possible trigger of primary biliary cirrhosis-like syndrome in a patient with multiple sclerosis in the course of fingolimod treatment.

scientific article published on December 2014

Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?

scientific article published on 01 January 2020

Fingolimod efficacy in multiple sclerosis associated with Sjogren syndrome

scientific article published on February 2015

Fingolimod reduces the clinical expression of active demyelinating lesions in MS.

scientific article published on 5 February 2018

Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis

scientific article published on 11 September 2015

Fluctuations of MS births and UV-light exposure.

scientific article

Healthcare resource utilization and costs for multiple sclerosis management in the Campania region of Italy: Comparison between centre-based and local service healthcare delivery

scientific article published on 19 September 2019

Integrated Cognitive and Neuromotor Rehabilitation in Multiple Sclerosis: A Pragmatic Study

article published in 2018

Intracranial extension of orbital inflammatory pseudotumor: a case report and literature review

scientific article

Isolated transient blindness and isolated oculomotor nerve palsy secondary to single mesencephalic metastases: report of 2 cases.

scientific article published in July 2012

Lymphocytosis as a response biomarker of natalizumab therapeutic efficacy in multiple sclerosis

scientific article

Migraine as possible red flag of PFO presence in suspected demyelinating disease

scientific article published on 30 April 2018

Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study

scientific article published on 13 July 2020

Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice.

scientific article published on 22 April 2012

Natalizumab vs interferon beta 1a in relapsing-remitting multiple sclerosis: a head-to-head retrospective study

scientific article published on 23 November 2011

No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study

scientific article published on 26 September 2018

Normalization of short-chain acylcoenzyme A dehydrogenase after riboflavin treatment in a girl with multiple acylcoenzyme A dehydrogenase-deficient myopathy

scientific article published on 01 May 1989

Ocrelizumab in a case of refractory Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) with antibodies anti Rituximab

scientific article published on 02 September 2020

Palatability and oral cavity tolerability of THC:CBD oromucosal spray and possible improvement measures in multiple sclerosis patients with resistant spasticity: a pilot study.

scientific article published on 23 April 2018

Patient satisfaction with ExtaviPro™ 30G, a new auto-injector for administering interferon β-1b in multiple sclerosis: results from a real-world, observational EXCHANGE study.

scientific article published on 09 August 2017

Post-marketing of disease modifying drugs in multiple sclerosis: an exploratory analysis of gender effect in interferon beta treatment.

scientific article published on 16 July 2009

Preliminary Results of the FASM Study, an On-Going Italian Active Pharmacovigilance Project

scientific article published on 15 December 2020

Prognostic indicators in pediatric clinically isolated syndrome

scientific article published on 25 April 2017

Real-life impact of early interferon beta therapy in relapsing multiple sclerosis.

scientific article

Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register

scientific article published on 18 September 2019

Revelation of a new mitochondrial DNA mutation (G12147A) in a MELAS/MERFF phenotype

scientific article (publication date: February 2004)

Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study.

scientific article published on 10 June 2016

Synergistic Interplay between Curcumin and Polyphenol-Rich Foods in the Mediterranean Diet: Therapeutic Prospects for Neurofibromatosis 1 Patients.

scientific article published on 21 July 2017

The EDSS integration with the Brief International Cognitive Assessment for Multiple Sclerosis and orientation tests.

scientific article published on 3 November 2016

The Rise of the GRN C157KfsX97 Mutation in Southern Italy: Going Back to the Fall of the Western Roman Empire

scientific article published on 28 September 2020

The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study.

scientific article

Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factors

scientific article published on 19 November 2020

Treatment withdrawal in relapsing-remitting multiple sclerosis: a retrospective cohort study.

scientific article published on 26 July 2015

Tumor necrosis factor-alpha and insulin-like growth factor-1 levels in patients with relapsing-remitting multiple sclerosis receiving interferon-beta1a.

scientific article published on May 2009

Unusual manifestation of vertebral osteoid osteoma: case report

scientific article published on 16 May 2001

Paulina is supported by:

About Paulina

Help